In a new study, researchers show that sun-exposed oyster mushrooms offer a readily available source of vitamin D that can help TB patients respond better to anti-TB drugs by improving immune response.
Many Americans get less than the recommended amount of sleep, and many do not consume the recommended amounts of important vitamins and minerals. A new study suggests the two factors may be connected.
The foods and nutrients a woman consumes while pregnant have important health implications for her and her baby. Nutrition 2019, the annual meeting of the American Society for Nutrition, will feature new research on prenatal vitamins, infant supplements and the impacts of a mother’s diet during pregnancy and after the baby is born.
The foods we eat can play an important role in preventing cancer. New modeling research presented at Nutrition 2019 shows that policies using taxes or warning labels to encourage healthier eating could reduce the number of people who develop cancer, which would bring significant savings in medical costs.
Drinks with added sugar, also known as sugar-sweetened beverages (SSBs), are one of the largest sources of added sugar in the American diet and a major contributor to obesity. SSBs include non-diet sodas, flavored juice drinks, sports drinks, sweetened tea, coffee drinks, energy drinks and electrolyte replacement drinks. Research presented at Nutrition 2019 will examine how various policies could help reduce the consumption of these sugary beverages and improve health.
Could changing what we eat lower the chances of developing type 2 diabetes? Studies presented at Nutrition 2019 will examine how consuming certain foods, vitamins and even the order in which we eat can affect blood sugar levels and risk of developing 2 diabetes.
The beverages we drink represent a substantial source of our daily calories and nutrients, yet standardized methods for tracking beverage consumption have been limited. In the latest and most comprehensive assessment of worldwide beverage consumption, researchers report substantial differences in the beverages consumed by different demographic groups in 185 countries.
Preliminary findings from a new study reveal that inadequate fruit and vegetable consumption may account for millions of deaths from heart disease and strokes each year. The study estimated that roughly 1 in 7 cardiovascular deaths could be attributed to not eating enough fruit and 1 in 12 cardiovascular deaths could be attributed to not eating enough vegetables.
Eating well, drinking enough water and taking certain supplements have all been shown to positively affect brain function in adults. Less is known about how these factors affect children. At Nutrition 2019, the annual meeting of the American Society for Nutrition, researchers announce new findings on the ways nutrition influences how children think, learn and behave.
Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that combination targeted therapy, consisting of rituximab, lenalidomide and ibrutinib (RLI), had an 84.6 percent overall response rate (ORR) and 38.5 percent complete response rate (CRR) when given prior to any chemotherapy for newly diagnosed patients with a specific type of diffuse large b-cell lymphoma (DLBCL).
The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.
There are no approved treatment options for patients with advanced bladder cancer after standard chemotherapy and immune treatments, but the results of a phase II clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers demonstrates an effective treatment for this deadly disease.
New studies on early detection of colorectal cancer and the quality-of-life impact of cell therapy are among several Mayo Clinic presentations at the American Society of Clinical Oncology annual meeting in Chicago.
Two studies that explore types of discrimination and gender bias in health care organizations will be presented by Mayo Clinic researchers at the American Society of Clinical Oncology annual meeting in Chicago.
Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene, and also by aromatase inhibitors. Nevertheless, women at high risk of breast cancer have a low acceptance of preventive medicine. A new study by Mayo Clinic and collaborators at the University of Manitoba and CancerCare Manitoba suggests that when women at high risk are presented with personalized genetic information, they're more likely to take preventative medications to reduce their chance of developing breast cancer. The research involved a new blood test developed by Mayo Clinic to identify women at higher genetic risk for developing breast cancer.
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response (MPR) rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery. With these results, the combination immunotherapy met the pre-specified trial efficacy endpoint of the phase II NEOSTAR trial conducted by researchers at The University of Texas MD Anderson Cancer Center.
With their phase II study in patients with aggressive brain cancer now completed, the developers of the cancer immunotherapy SurVaxM report that combination therapy with the vaccine was more effective than standard therapy for nearly all patients.
Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer (mHSPC), according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology, during the American Society of Clinical Oncology (ASCO) Annual Meeting.
The largest randomized trial involving smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of myeloma symptoms, according to Mayo Clinic researchers. The study was conducted by the Eastern Cooperative Oncology Group and funded by the National Cancer Institute.
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Researchers found just 15 percent of a group of men with early-stage prostate cancer received biopsies and other tests according to active surveillance guidelines from the National Comprehensive Cancer Network.
Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer
Findings from Rutgers Cancer Institute of New Jersey focused on immunotherapy will be featured at the 2019 American Society of Clinical Oncology Annual Meeting being held in Chicago tomorrow through Tuesday.
Cancer patients previously excluded and underrepresented in immunotherapy clinical trials, such as African Americans and patients with HIV or viral hepatitis, actually benefit at the same rate as patients tested in the clinical trials, according to a Georgetown-led study to be presented at the 2019 ASCO Annual Meeting in Chicago.
A survey conducted by Georgetown investigators found a significant knowledge and practice gap among community oncologists in the understanding and usage of genetic testing in determining patients' treatment plans and potential clinical trial outcomes.
ISPOR, the professional society for health economics and outcomes research, recently concluded its ISPOR 2019 annual conference in New Orleans, LA, USA.
ISPOR, the professional society for health economics and outcomes research, examined the issue of patient access and biosimilars this afternoon at its ISPOR 2019 annual conference.
Patients with chronic obstructive pulmonary disease, or COPD, who are covered by a high-deductible insurance plan are more likely to forgo needed health care because of cost than COPD patients covered by lower-deductible plans
ISPOR, the professional society for health economics and outcomes research, held its final plenary of the ISPOR 2019 annual conference with, “Is Healthcare Affordability Driving a Need to Revolutionize Drug Pricing?”
Redlining, the discriminatory mortgage-lending practice, may affect how prevalent asthma is in the neighborhood, according to research presented at ATS 2019.
Using machine learning to analyze jaw movements during sleep, doctors may be able to diagnose obstructive sleep apnea in patients with mild to severe OSA with an accuracy comparable to polysomnography, the gold standard for OSA diagnosis,
The airway microbiome appears to be altered in patients with severe asthma linked to high levels of white blood cells called neutrophils, according to new research presented at ATS 2019.
Fewer deaths and serious illnesses have occurred in the U.S. over the past decade as a result of cleaner air, according to a new report focusing on the two most potent air pollutants: fine particle (PM2.5) and ground-level ozone (O3). However, these improvements are almost entirely due to reductions in PM2.5 pollution.
Three hospital-acquired infections rates appear to be lower in patients admitted to a “closed” intensive care unit, meaning that the ICU team has primary responsibility for the patient, rather than a primary care physician, according to research presented at ATS 2019.
ISPOR, the professional society for health economics and outcomes research, explored the possibility of health technology assessment in the United States this morning at its ISPOR 2019.
People who smoke unfiltered cigarettes are nearly twice as likely to die from lung cancer and 30 percent more likely to die of all causes than those who smoke filtered cigarettes
Exposure to violence, depression and poor health habits – including obesity, drinking soda, poor sleep and smoking marijuana – appear to be associated with asthma in high school students, according to research presented at ATS 2019.
Women who develop COPD report smoking fewer cigarettes than men; and yet, women experience greater breathing impairments, are subjected to more acute exacerbations of symptoms and report lower quality of life than men with the disease, according to research presented at ATS 2019.
In a new study, researchers at Intermountain Healthcare in Salt Lake City found that antibiotic delivery was significantly faster — by up to 32 minutes — for sepsis patients being treated in an emergency department if they were assigned a slightly higher score on a subjective one-to-five acuity scale commonly used for patient triage.
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of experiencing side-effects from their radiation therapy, while cure rates are almost identical between the two groups.
ISPOR, the professional society for health economics and outcomes research (HEOR), held a session for its Women in HEOR initiative yesterday late afternoon at its ISPOR 2019 annual conference in New Orleans, LA, USA.
Proton therapy results in fewer side effects than traditional X-ray radiation therapy for many cancer patients, according to a new study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at University of Pennsylvania. Even with reduced side effects, proton therapy resulted in cure rates similar to those of X-ray radiation therapy.
A specialized pain management program for patients who underwent robotic surgery for urologic cancers resulted in just eight percent going home with narcotics after discharge, compared to 100 percent who would have received them without this enhanced recovery protocol.
ISPOR, the professional society for health economics and outcomes research (HEOR), examined how real-world evidence can be improved with patient-provided information this afternoon at its ISPOR 2019 annual conference.
ISPOR, the professional society for health economics and outcomes research (HEOR), explored the future of HEOR for the 2020s this afternoon at its ISPOR 2019 annual conference.
Mayo Clinic researchers are among international experts who will present findings next week at Digestive Disease Week 2019, the world's largest gathering of physicians, researchers and industry leaders in gastroenterology and related fields.
Retinal vascular tortuosity, a microvascular abnormality of the eye, may provide doctors with a noninvasive way of determining the extent of vascular remodeling in patients with pulmonary arterial hypertension,
Increased use of primary care may reduce rates of respiratory failure and admissions to the intensive care unit, according to research presented at ATS 2019.
COPD patients who were given a pedometer and participated in a web-based intervention that helped them set physical activity goals, provided feedback and disease self-management education, and offered a community forum were less likely to experience an acute exacerbation of their lung disease than those patients who received only the pedometer,
ISPOR, the professional society for health economics and outcomes research, started the day with the second plenary session of its ISPOR 2019 annual conference with, “Medical Device Innovation and Regulation: Turbocharged for Success?"
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right